(S)-ethyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-2-(1,3-dimethyl-1H-indazol-6-yl)-5-methylbenzo[d]thiazol-6-yl)acetate → (S)-ethyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-5-methyl-2-(3-methyl-[1,2,3]triazolo[1,5-a]pyridin-5-yl)benzo[d]thiazol-6-yl)acetate

Participants

Reaction Steps

Prepared in a manner similar to (S)-ethyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-2-(1,3-dimethyl-1H-indazol-6-yl)-5-methylbenzo[d]thiazol-6-yl)acetate, but using 3-methyl-[1,2,3]triazolo[1,5-a]pyridin-5-ylboronic acid instead of 1,3-dimethyl-1H-indazol-6-ylboronic acid. 1H NMR (400 MHz, CDCl3) δ 8.68 (d, J=7.4 Hz, 1H), 8.21 (s, 1H), 7.91 (s, 1H), 7.66 (dd, J=7.4, 1.6 Hz, 1H), 7.61-7.50 (m, 3H), 7.50-7.43 (m, 1H), 5.17 (s, 1H), 4.27-4.17 (m, 2H), 2.67 (s, 3H), 2.62 (s, 3H), 1.30-1.22 (m, 3H), 0.99 (s, 9H).

Provenance & Evidence